Laboratorios Farma | ROVI - Marktkapitalisierung

Aktienkurs
81.10
Täglich Wechseln
-3.80 -4.48%
Monatlich
2.27%
Jährlich
58.55%
Q2 Prognose
79.04




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Almirall EUR 2.76B 472.53M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 29.18B 9.2B 2026-04
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Organon & Co USD 1.86B 916.43M 2025-12
Pharma Mar EUR 1.67B 317.89M 2026-04
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12